1 |
World Health Organization. Global Tuberculosis Report 2013. Geneva: World Health Organization, 2013.
|
2 |
Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-226.
DOI
ScienceOn
|
3 |
Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martin-Casabona N, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis 2007;13:380-387.
DOI
ScienceOn
|
4 |
Marrakchi H, Laneelle G, Quemard A. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology 2000;146(Pt 2):289-296.
DOI
|
5 |
Calvori C, Frontali L, Leoni L, Tecce G. Effect of rifamycin on protein synthesis. Nature 1965;207:417-418.
DOI
|
6 |
Yang B, Koga H, Ohno H, Ogawa K, Fukuda M, Hirakata Y, et al. Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother 1998;42:621-628.
DOI
ScienceOn
|
7 |
Kolyva AS, Karakousis PC. Old and new TB drugs: mechanisms of action and resistance: In: Understanding Tuberculosis: New Approaches to Fighting against Drug Resistance (Cardona JP, ed.). Rijeka: InTech, 2011. pp. 209-232.
|
8 |
Wade MM, Zhang Y. Mechanisms of drug resistance in Mycobacterium tuberculosis. Front Biosci 2004;9:975-994.
DOI
|
9 |
Somasundaram S, Ram A, Sankaranarayanan L. Isoniazid and rifampicin as therapeutic regimen in the current era: a review. J Tuberc Res 2014;2:40-51.
DOI
|
10 |
Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc Lung Dis 1998;79:3-29.
DOI
ScienceOn
|
11 |
Zhang Y, Telenti A. Genetics of drug resistance in Mycobacterium tuberculosis. In: Molecular Genetics of Mycobacteria (Hatfull GF, Jacobs WR Jr, eds.). Washington DC: ASM Press, 2000. pp. 235-254.
|
12 |
Brandis G, Hughes D. Genetic characterization of compensatory evolution in strains carrying rpoB Ser531Leu, the rifampicin resistance mutation most frequently found in clinical isolates. J Antimicrob Chemother 2013;68:2493-2497.
DOI
|
13 |
Tang K, Sun H, Zhao Y, Guo J, Zhang C, Feng Q, et al. Characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Sichuan in China. Tuberculosis (Edinb) 2013;93:89-95.
DOI
|
14 |
Kapur V, Li LL, Iordanescu S, Hamrick MR, Wanger A, Kreiswirth BN, et al. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994;32:1095-1098.
|
15 |
Kelley LA, Sternberg MJ. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 2009;4:363-371.
DOI
ScienceOn
|
16 |
Eswar N, Eramian D, Webb B, Shen MY, Sali A. Protein structure modeling with MODELLER. Methods Mol Biol 2008;426:145-159.
DOI
|
17 |
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 2009;30:2785-2791.
DOI
ScienceOn
|
18 |
Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J, et al. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins 2009;77 Suppl 9:114-122.
DOI
|
19 |
Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993;26:283-291.
DOI
ScienceOn
|
20 |
Wallner B, Elofsson A. Can correct protein models be identified? Protein Sci 2003;12:1073-1086.
DOI
|
21 |
Hess B, Kutzner C, van Der Spoel D, Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008;4:435-447.
DOI
ScienceOn
|
22 |
Schuttelkopf AW, van Aalten DM. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr 2004;60:1355-1363.
DOI
ScienceOn
|
23 |
Berendsen HJ, Grigera JR, Straatsma TP. The missing term in effective pair potentials. J Phys Chem 1987;91:6269-6271.
DOI
|
24 |
Hess B, Bekker H, Berendsen HJ, Fraaije JG. LINCS: a linear constraint solver for molecular simulations. J Comput Chem 1997;18:1463-1472.
DOI
ScienceOn
|
25 |
Bussi G, Donadio D, Parrinello M. Canonical sampling through velocity rescaling. J Chem Phys 2007;126:014101.
DOI
ScienceOn
|
26 |
Opalka N, Brown J, Lane WJ, Twist KA, Landick R, Asturias FJ, et al. Complete structural model of Escherichia coli RNA polymerase from a hybrid approach. PLoS Biol 2010;8:e1000483.
DOI
|
27 |
Parrinello M, Rahman A. Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 1981;52:7182-7190.
DOI
ScienceOn
|
28 |
Darden T, York D, Pedersen L. Particle mesh Ewald: an N.log(N) method for Ewald sums in large systems. J Chem Phys 1993;98:10089-10092.
DOI
ScienceOn
|
29 |
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007;23:2947-2948.
DOI
ScienceOn
|
30 |
Mitra PP. Drug discovery in tuberculosis: a molecular approach. Indian J Tuberc 2012;59:194-206.
|
31 |
Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH. PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res 2009;37:W623-W633.
DOI
|
32 |
Telenti A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993;341:647-650.
DOI
ScienceOn
|
33 |
Rahmo A, Hamdar Z, Kasaa I, Dabboussi F, Hamze M. Genotypic detection of rifampicin-resistant M. tuberculosis strains in Syrian and Lebanese patients. J Infect Public Health 2012;5:381-387.
DOI
|
34 |
Wiederstein M, Sippl MJ. ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 2007;35:W407-W410.
DOI
|